Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease or Disorder”

9,669 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 9,669 results

Not applicableActive Not RecruitingNCT07191574
What this trial is testing

Stress CMR With Vasodilators to Predict Long-Term Mortality

Who this might be right for
Ischemic Heart Disease (IHD)Magnetic Resonance
Fundación para la Investigación del Hospital Clínico de Valencia 5,552
Testing effectiveness (Phase 2)Active Not RecruitingNCT04734990
What this trial is testing

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia-0Chronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+3 more
M.D. Anderson Cancer Center 24
Early research (Phase 1)Looking for participantsNCT06708897
What this trial is testing

Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

Who this might be right for
CLL / SLLCLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)+2 more
Lomond Therapeutics Holdings, Inc. 84
Not applicableEnded earlyNCT05252910
What this trial is testing

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents

Who this might be right for
COVID-19
Pharm-Olam, LLC 33
Not applicableStudy completedNCT04890262
What this trial is testing

Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice

Who this might be right for
Inflammatory Bowel DiseasesCrohns DiseaseColitis, Ulcerative
Takeda 99
Not applicableStudy completedNCT02662946
What this trial is testing

Evaluation of Intestinal Vascolarization With Indocianine Green Angiography During Rectal Resection or Left Colectomy

Who this might be right for
Rectal DiseaseSigmoid Disease
Scientific Institute San Raffaele 208
Testing effectiveness (Phase 2)Study completedNCT02061761
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Hematologic Neoplasms
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Study completedNCT00003413
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
University of Maryland, Baltimore 32
Testing effectiveness (Phase 2)Study completedNCT00065260
What this trial is testing

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 54
Post-approval studies (Phase 4)UnknownNCT06571942
What this trial is testing

Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure

Who this might be right for
COPD BronchitisPollution Related Respiratory Disorder
National Institute of Respiratory Diseases, Mexico 128
Not applicableStudy completedNCT06237673
What this trial is testing

The "CAD-Man" EXTEND Study

Who this might be right for
Coronary Artery Disease
Charite University, Berlin, Germany 318
Early research (Phase 1)Looking for participantsNCT07586618
What this trial is testing

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Who this might be right for
Lymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL
Allterum Therapeutics, Inc 24
Large-scale testing (Phase 3)Study completedNCT01792518
What this trial is testing

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 360
Post-approval studies (Phase 4)Study completedNCT00137020
What this trial is testing

Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 294
Not applicableUnknownNCT01939080
What this trial is testing

Variation of Aortic Compliance Related to Exercise Training With or Without Supervised Sessions

Who this might be right for
Cardiovascular Disease
University Hospital Center of Martinique 308
Early research (Phase 1)Study completedNCT00058396
What this trial is testing

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT04203446
What this trial is testing

Factors Influencing on Correctness of Inhalation Technique.

Who this might be right for
AsthmaCOPD
Medical University of Warsaw 180
Testing effectiveness (Phase 2)Ended earlyNCT02078960
What this trial is testing

Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 10
Not applicableLooking for participantsNCT04846959
What this trial is testing

Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

Who this might be right for
Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment
AbbVie 818
Post-approval studies (Phase 4)Looking for participantsNCT06876662
What this trial is testing

(LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company 279
Next Page